New Haven, Connecticut 06510

  • Insulin Resistance

Purpose:

To explore whether obese adolescents with insulin resistance and relative low leptin levels exhibit functional alterations of the neuronal circuits involved in the regulation of energy metabolism and food seeking behaviors. We here propose to test the hypothesis that the reward circuitry is dysregulated in obese adolescents and is related to the degree of insulin resistance and hyperinsulinemia.


Study summary:

Functional Magnetic Resonance Imaging (fMRI) provides a non-invasive method to assess the functional pathways affected by nutrient ingestion and therefore can help answer important questions regarding potential differences in the response of brain regions involved in feeding.


Criteria:

Inclusion Criteria: - Obese adolescents - Good general health, - taking no medication on a chronic basis - Age 12 to 17 yrs, - in puberty (girls and boys: Tanner stage II - IV) Obese Insulin Resistant Adolescents - (BMI> 95th) - (WBISI<1.2 plus a low adiponectin <6 ug/dl and - high triglyceride levels >130mg/dl) Obese Insulin Sensitive Adolescents - (BMI>95th) - (WBISI >3) plus high adiponectin >8 ug/ml and - triglyceride levels > 80 mg/dl Girls who begin menstruating must have a negative pregnancy test during the study Eligibility criteria for healthy non-obese children and adolescents: - Brother or sister with obesity - Age 12 to 17 years - Normal fasting glucose and lipids in the child, and - normal OGTT - No use of any medication known to affect glucose, lipid metabolism and inflammation - No endocrinopathies - No use of any antipsychotic medication - BMI >25th to <75th ( Center for Disease Control (CDC) BMI Charts) - Minimum weight of 90lbs (CDC Growth Charts) Exclusion Criteria - Baseline creatinine >1.0 mg - Pregnancy - Presence of endocrinopathies (e.g. Cushing syndrome) - Cardiac or pulmonary or other significant chronic illness - Adolescents with psychiatric disorder or with substance abuse determined via self-report. - Use of anorexic agents No metal implants


NCT ID:

NCT01808846


Primary Contact:

Principal Investigator
Sonia Caprio, M.D.
Yale University

Bridget Pierpont, M.A.
Phone: 203-785-2942


Backup Contact:

N/A


Location Contact:

New Haven, Connecticut 06510
United States

Bridget Pierpont, M.A.
Phone: 203-785-2942

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.